These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8289194)

  • 1. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
    Sum PE; Lee VJ; Testa RT; Hlavka JJ; Ellestad GA; Bloom JD; Gluzman Y; Tally FP
    J Med Chem; 1994 Jan; 37(1):184-8. PubMed ID: 8289194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
    Macone AB; Caruso BK; Leahy RG; Donatelli J; Weir S; Draper MP; Tanaka SK; Levy SB
    Antimicrob Agents Chemother; 2014; 58(2):1127-35. PubMed ID: 24295985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
    Xiao XY; Hunt DK; Zhou J; Clark RB; Dunwoody N; Fyfe C; Grossman TH; O'Brien WJ; Plamondon L; Rönn M; Sun C; Zhang WY; Sutcliffe JA
    J Med Chem; 2012 Jan; 55(2):597-605. PubMed ID: 22148514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
    Sum PE; Petersen P
    Bioorg Med Chem Lett; 1999 May; 9(10):1459-62. PubMed ID: 10360756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in tetracycline antibiotics.
    Sum PE; Sum FW; Projan SJ
    Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.
    Projan SJ
    Pharmacotherapy; 2000 Sep; 20(9 Pt 2):219S-223S; discussion 224S-228S. PubMed ID: 11001329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 8-aminomethyltetracycline derivatives as novel antibacterial agents.
    Clark RB; He M; Deng Y; Sun C; Chen CL; Hunt DK; O'Brien WJ; Fyfe C; Grossman TH; Sutcliffe JA; Achorn C; Hogan PC; Katz CE; Niu J; Zhang WY; Zhu Z; Ronn M; Xiao XY
    J Med Chem; 2013 Oct; 56(20):8112-38. PubMed ID: 24047201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
    Clark RB; He M; Fyfe C; Lofland D; O'Brien WJ; Plamondon L; Sutcliffe JA; Xiao XY
    J Med Chem; 2011 Mar; 54(5):1511-28. PubMed ID: 21302930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 9-substituted tetracycline derivatives.
    Koza DJ; Nsiah YA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2163-5. PubMed ID: 12127528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.
    Nelson ML; Park BH; Levy SB
    J Med Chem; 1994 Apr; 37(9):1355-61. PubMed ID: 8176712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
    Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7044-53. PubMed ID: 26349824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.
    Rasmussen BA; Gluzman Y; Tally FP
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1658-60. PubMed ID: 7526784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.
    Weiss WJ; Jacobus NV; Petersen PJ; Testa RT
    J Antimicrob Chemother; 1995 Jul; 36(1):225-30. PubMed ID: 8537270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
    Someya Y; Yamaguchi A; Sawai T
    Antimicrob Agents Chemother; 1995 Jan; 39(1):247-9. PubMed ID: 7695316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides.
    Barden TC; Buckwalter BL; Testa RT; Petersen PJ; Lee VJ
    J Med Chem; 1994 Sep; 37(20):3205-11. PubMed ID: 7932547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of a tetracycline-platinum (II) complex active against resistant bacteria.
    Chartone-Souza E; Loyola TL; Bucciarelli-Rodriguez M; Menezes MA; Rey NA; Pereira-Maia EC
    J Inorg Biochem; 2005 May; 99(5):1001-8. PubMed ID: 15833322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and antibacterial activity of three palladium(II) complexes of tetracyclines.
    Guerra W; de Andrade Azevedo E; de Souza Monteiro AR; Bucciarelli-Rodriguez M; Chartone-Souza E; Nascimento AM; Fontes AP; Le Moyec L; Pereira-Maia EC
    J Inorg Biochem; 2005 Dec; 99(12):2348-54. PubMed ID: 16226807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection.
    Bergeron J; Ammirati M; Danley D; James L; Norcia M; Retsema J; Strick CA; Su WG; Sutcliffe J; Wondrack L
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2226-8. PubMed ID: 8878615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.